Castle Biosciences to Participate in Upcoming Investor Conferences
Castle Biosciences (Nasdaq: CSTL) said its executive management will present a company overview at the Stephens 27th Annual Investment Conference on Nov 19, 2025 at 10:00 a.m. ET. A live audio webcast will be available at the company’s investor website and a replay will be posted after the broadcast. Castle also will be available for one-on-one investor meetings at the Jefferies Global Healthcare Conference on Nov 18–20, 2025, with meetings requestable through Jefferies Financial Group.
Castle Biosciences (Nasdaq: CSTL) ha dichiarato che i suoi dirigenti esecutivi presenteranno una panoramica dell'azienda durante la 27ª Conferenza Annuale sugli Investimenti di Stephens il 19 novembre 2025 alle ore 10:00 ET. Una diretta audio webcast sarà disponibile sul sito di investitori dell'azienda e una replica sarà pubblicata dopo la trasmissione. Castle sarà inoltre disponibile per incontri individuali con investitori alla Conferenza globale sulla sanità Jefferies dal 18 al 20 novembre 2025, con richieste di incontro gestite da Jefferies Financial Group.
Castle Biosciences (Nasdaq: CSTL) dijo que su alta dirección presentará una visión general de la empresa en la 27.ª Conferencia Anual de Inversiones de Stephens el 19 de noviembre de 2025 a las 10:00 a. m. hora del Este. Una transmisión en vivo de audio estará disponible en el sitio web para inversores de la empresa y se publicará una repetición después de la transmisión. Castle también estará disponible para reuniones con inversores uno a uno en la Conferencia Global de Atención Sanitaria Jefferies del 18 al 20 de noviembre de 2025, con solicitudes de reuniones gestionadas a través de Jefferies Financial Group.
Castle Biosciences(Nasdaq: CSTL)의 경영진은 Stephens 27th Annual Investment Conference에서 회사 개요를 발표할 예정이며 2025년 11월 19일 동부표준시 10:00에 시작됩니다. 라이브 오디오 생방송은 회사의 투자자 웹사이트에서 이용 가능하며 방송 후 재생이 게시됩니다. Castle은 또한 Jefferies Global Healthcare Conference에서 2025년 11월 18-20일에 1:1 투자자 미팅을 위해 대기 중이며 Jefferies Financial Group을 통해 미팅 요청이 가능합니다.
Castle Biosciences (Nasdaq : CSTL) a déclaré que son équipe exécutive présentera une vue d’ensemble de l’entreprise lors de la 27e conférence annuelle sur les investissements de Stephens le 19 novembre 2025 à 10h00 ET. Une webdiffusion audio en direct sera disponible sur le site Web des investisseurs de l’entreprise et une rediffusion sera publiée après la diffusion. Castle sera également disponible pour des réunions avec des investisseurs en tête-à-tête lors de la Conférence mondiale sur les soins de santé Jefferies du 18 au 20 novembre 2025, les demandes de réunions étant possibles via Jefferies Financial Group.
Castle Biosciences (Nasdaq: CSTL) sagte, dass das Geschäftsführerteam bei der Stephens 27th Annual Investment Conference eine Unternehmensübersicht präsentieren wird am 19. November 2025 um 10:00 Uhr Eastern Time. Eine Live-Audio-Übertragung wird auf der Investorenseite des Unternehmens verfügbar sein, und eine Wiederholung wird nach der Übertragung veröffentlicht. Castle wird außerdem für One-on-One-Investorenmeetings bei der Jefferies Global Healthcare Conference vom 18.–20. November 2025 zur Verfügung stehen, Anfragen für Meetings erfolgen über Jefferies Financial Group.
Castle Biosciences (نازداك: CSTL) ذكرت أن فريق الإدارة التنفيذية سيقدم لمحة عامة عن الشركة في الملتقى السنوي السابع والعشرين لاستثمارات ستيفنز في 19 نوفمبر 2025 الساعة 10:00 صباحًا بتوقيت شرق الولايات المتحدة. ستتوفر بث صوتي مباشر عبر موقع المستثمرين الخاص بالشركة، وسيتم نشر إعادة البث بعد البث. كما ستكون Castle متاحة أيضًا للاجتماعات الاستثمارية الواحدة لواحدة في مؤتمر Jefferies العالمي للرعاية الصحية في 18–20 نوفمبر 2025، مع إمكانية طلب الاجتماعات من خلال Jefferies Financial Group.
Castle Biosciences (纳斯达克：CSTL) 的执行管理层将于Stephens第27届年度投资会议上提供公司概览，时间为2025年11月19日美东时间上午10:00。公司投资者网站将提供现场音频网络直播，广播结束后将发布回放。Castle 还将于2025年11月18–20日在Jefferies全球医疗保健大会举行一对一投资者会议，会议请求通过 Jefferies Financial Group 提交。
- None.
- None.
FRIENDSWOOD, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Stephens 27th Annual Investment Conference on Wednesday, Nov. 19, 2025, at 10:00 a.m. Eastern time.
A live audio webcast of the Company’s presentation will be available by visiting Castle Biosciences’ website at ir.castlebiosciences.com/events-presentations/. A replay of the webcast will be available following the conclusion of the live broadcast.
Castle will also be available for one-on-one investor meetings during the Jefferies Global Healthcare Conference, being held Nov. 18-20, 2025. Meetings may be requested exclusively through Jefferies Financial Group.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide treatment decisions for patients with moderate-to-severe atopic dermatitis. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
Allison Marshall
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
When will Castle Biosciences (CSTL) present at the Stephens 27th Annual Investment Conference?
How can investors access Castle Biosciences (CSTL) presentation webcast on Nov 19, 2025?
Will Castle Biosciences (CSTL) hold meetings at the Jefferies Global Healthcare Conference Nov 18–20, 2025?
Does the Castle Biosciences (CSTL) webcast include a replay if I miss the live presentation?
Where can institutional investors request one-on-one meetings with Castle Biosciences (CSTL) at Jefferies?
